Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MiR‐200c suppresses TGF‐β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer
Wendong Bai, X. Ye, M. Zhang, et al.
International Journal of Cancer (2014) Vol. 135, Iss. 6, pp. 1356-1368
Open Access | Times Cited: 162

Showing 26-50 of 162 citing articles:

Non-coding RNAs as potential therapeutic targets in breast cancer
Deepti Tomar, Amit Singh Yadav, Dhiraj Kumar, et al.
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2019) Vol. 1863, Iss. 4, pp. 194378-194378
Closed Access | Times Cited: 78
Interaction between HLA-G and NK cell receptor KIR2DL4 orchestrates HER2-positive breast cancer resistance to trastuzumab
Guoxu Zheng, Zhangyan Guo, Weimiao Li, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 75
Drug-resistant HER2-positive breast cancer: Molecular mechanisms and overcoming strategies
Xiaofan Wu, Hongjian Yang, Xingfei Yu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 42
Decoding contextual crosstalk: revealing distinct interactions between non-coding RNAs and unfolded protein response in breast cancer
Negin Karamali, Arshia Daraei, Arman Rostamlou, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 9
Glabridin inhibits cancer stem cell-like properties of human breast cancer cells: An epigenetic regulation of miR-148a/SMAd2 signaling
Fei Jiang, Yuan Li, Juan Mu, et al.
Molecular Carcinogenesis (2015) Vol. 55, Iss. 5, pp. 929-940
Closed Access | Times Cited: 89
Hsa-miR-19a is associated with lymph metastasis and mediates the TNF-α induced epithelial-to-mesenchymal transition in colorectal cancer
Lan Huang, Xiaoyan Wang, Chuangyu Wen, et al.
Scientific Reports (2015) Vol. 5, Iss. 1
Open Access | Times Cited: 78
miR-9 and miR-200 Regulate PDGFRβ-Mediated Endothelial Differentiation of Tumor Cells in Triple-Negative Breast Cancer
Elvira D’Ippolito, Ilaria Plantamura, Lucia Bongiovanni, et al.
Cancer Research (2016) Vol. 76, Iss. 18, pp. 5562-5572
Open Access | Times Cited: 78
UCA1 confers paclitaxel resistance to ovarian cancer through miR-129/ABCB1 axis
Junrong Wang, Cong Ye, Junbao Liu, et al.
Biochemical and Biophysical Research Communications (2018) Vol. 501, Iss. 4, pp. 1034-1040
Closed Access | Times Cited: 78
Downregulation of microRNA-362-3p and microRNA-329 promotes tumor progression in human breast cancer
Hyun Tae Kang, C Kim, Hsiu‐Hsiang Lee, et al.
Cell Death and Differentiation (2015) Vol. 23, Iss. 3, pp. 484-495
Open Access | Times Cited: 77
miR-200c inhibits TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer
Xinliang Zhou, Xinyi Men, Riyang Zhao, et al.
Cancer Gene Therapy (2018) Vol. 25, Iss. 3-4, pp. 68-76
Closed Access | Times Cited: 77
Dynamic and Modularized MicroRNA Regulation and Its Implication in Human Cancers
Jiang Shu, Bruno Vieira Resende E Silva, Tian Gao, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 75
Overexpression of suppressive microRNAs, miR-30a and miR-200c are associated with improved survival of breast cancer patients
Tsutomu Kawaguchi, Li Yan, Qianya Qi, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 73
Targeting Autophagy for Overcoming Resistance to Anti-EGFR Treatments
Yoojung Kwon, Mi-Sun Kim, Hyun Suk Jung, et al.
Cancers (2019) Vol. 11, Iss. 9, pp. 1374-1374
Open Access | Times Cited: 73
Long non-coding RNA UCA1 desensitizes breast cancer cells to trastuzumab by impeding miR-18a repression of Yes-associated protein 1
Huayu Zhu, Wendong Bai, Xingming Ye, et al.
Biochemical and Biophysical Research Communications (2018) Vol. 496, Iss. 4, pp. 1308-1313
Closed Access | Times Cited: 69
MicroRNAs in cancer drug resistance: Basic evidence and clinical applications
Mehri Ghasabi, Behzad Mansoori, Ali Mohammadi, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 3, pp. 2152-2168
Closed Access | Times Cited: 68
The role of TGF-β and its crosstalk with RAC1/RAC1b signaling in breast and pancreas carcinoma
Catharina Melzer, Ralf Hass, Juliane von der Ohe, et al.
Cell Communication and Signaling (2017) Vol. 15, Iss. 1
Open Access | Times Cited: 66
Knockdown of lncRNA-ATB suppresses autocrine secretion of TGF-β2 by targeting ZNF217 via miR-200c in keloid fibroblasts
Huayu Zhu, Wendong Bai, Chao Li, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 65
Circ‐RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR‐140‐5p
Hong-Liang Zang, Yuhui Li, Xue Zhang, et al.
Thoracic Cancer (2020) Vol. 11, Iss. 7, pp. 1891-1903
Open Access | Times Cited: 63
Cluster miRNAs and cancer: Diagnostic, prognostic and therapeutic opportunities
Shama Prasada Kabekkodu, Vaibhav Shukla, Vinay Koshy Varghese, et al.
Wiley Interdisciplinary Reviews - RNA (2019) Vol. 11, Iss. 2
Closed Access | Times Cited: 61
Breast Cancer Drug Resistance: Overcoming the Challenge by Capitalizing on MicroRNA and Tumor Microenvironment Interplay
Giulia Cosentino, Ilaria Plantamura, Elda Tagliabue, et al.
Cancers (2021) Vol. 13, Iss. 15, pp. 3691-3691
Open Access | Times Cited: 44
Cisplatin resistance-related multi-omics differences and the establishment of machine learning models
Qihai Sui, Zhencong Chen, Zhengyang Hu, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 33
Spatial and Temporal Relationship between Epithelial–Mesenchymal Transition (EMT) and Stem Cells in Cancer
Petra den Hollander, Joanna Joyce Maddela, Sendurai A. Mani
Clinical Chemistry (2024) Vol. 70, Iss. 1, pp. 190-205
Open Access | Times Cited: 8
The Role of MicroRNAs in the Chemoresistance of Breast Cancer
Jing Wang, Muyi Yang, Yu Li, et al.
Drug Development Research (2015) Vol. 76, Iss. 7, pp. 368-374
Closed Access | Times Cited: 64
The role of microRNAs in human breast cancer progression
WenCheng Zhang, Jinbo Liu, Guangshun Wang
Tumor Biology (2014) Vol. 35, Iss. 7, pp. 6235-6244
Closed Access | Times Cited: 64
The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value
Pascale A. Cohen, Caterina F. Donini, Nhan Trung Nguyen, et al.
Oncotarget (2015) Vol. 6, Iss. 39, pp. 41566-41581
Open Access | Times Cited: 58

Scroll to top